Editors Choice

HT World Correspondent and Medika Editor Gil Bashe Talks with the Medika50 Influencer Who Put Everything On the Line for Patients

In an exclusive video interview, hear how Dr. Kellie Stecher’s views on the great post-pandemic healthcare resignation, addressing systematic racism in healthcare – and the emerging possibilities of tech in maternal care.

Earlier this year she was named one of the 50 top healthcare influencers by respected journal Medika Life  – in part a recognition of her work addressing inequalities, racism and sexism in maternal health.

Gil Bashe, Medika Life Editor

Health advocate connecting the dots to transform biopharma, digital health and healthcare innovation | Managing Partner, Chair Global Health FINN Partners | MM&M Top 50 Health Influencer | Top 10 Innovation Catalyst. Gil is Medika Life editor-in-chief and an author for the platform’s EcoHealth and Health Opinion and Policy sections. Gil also hosts the HealthcareNOW Radio show Healthunabashed, writes for Health Tech World, and is a member of the BeingWell team on Medium.

Recent Posts

Death Is Not A Failure

In my conversation with Dr. Elaine Chen of Rush University Medical Center, who is both…

1 day ago

Executive action may actually drive up medicines prices

*This story will be updated as more details become available* President Trump’s executive order could…

4 days ago

Trump’s Drug Price Gambit: Cheaper for America, But Who Pays the Price?

Donald Trump is back at it, making big waves in the world of pharmaceuticals. On…

4 days ago

Cancer Isn’t Random: What 42% of Diagnoses Have in Common — and How You Can Lower Your Risk.

“The fault, dear Brutus, is not in our stars, but in ourselves…”— William Shakespeare, Julius Caesar.…

2 weeks ago

When Is Exercise Not Exercise, and Is That Good Enough?

Going for walks, dancing, and doing housework —although not technically exercises —any kind of movement counts toward your…

2 weeks ago

How Real-World Evidence Proves the Power of Patient Engagement

Data isn’t just an asset—it’s a trust marker. In life sciences, our credibility hinges on…

3 weeks ago

This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.

Read More